Drug may unlock Brain's ability to relearn walking after spinal injury
NCT ID NCT05217498
Summary
This study is testing whether a drug called istradefylline can help people with chronic spinal cord injuries walk better. The drug is designed to boost the benefits of a special low-oxygen breathing therapy combined with walking practice. Researchers will enroll 40 participants to see if this combination improves walking speed, distance, and strength more than the therapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Spaulding Rehabilitation Hospital
Cambridge, Massachusetts, 02138, United States
Conditions
Explore the condition pages connected to this study.